Allergan plc (AGN.N)
19 Oct 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|47||2016||Chairman of the Board, President, Chief Executive Officer|
|49||2016||Chief Operating Officer|
|53||2016||Chief Human Resource Officer|
|46||2013||Chief Accounting Officer|
|49||2016||Chief Commercial Officer|
- UPDATE 2-Imprimis Pharma to take on Allergan's Restasis with cheaper product
- BRIEF-Imprimis Pharma CEO says company intends to start selling prescriptions for its cheaper alternative to Restasis on Nov 1
- Imprimis Pharma to take on Allergan's Restasis with cheaper product
- UPDATE 1-Native American tribe holding patents sues Amazon and Microsoft
- Native American tribe holding patents sues Amazon and Microsoft